Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures mRNA Vaccine Platform Shows Promise Against Pandemic Influenza Strains, Including H5N1Global Biodefense StaffApril 26, 2026
Medical Countermeasures UK Launches Phase 3 Trial of mRNA H5N1 Vaccine in Bid to Get Ahead of Next PandemicGlobal Biodefense StaffApril 23, 2026
Tekmira Enters Phase II Ebola Clinical Study in Sierra Leone Medical Countermeasures March 11, 2015 …